Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis
Qian Wang, … , Zhi Yao, Lei Shi
Qian Wang, … , Zhi Yao, Lei Shi
Published May 16, 2016
Citation Information: J Clin Invest. 2016;126(6):2205-2220. https://doi.org/10.1172/JCI85747.
View: Text | PDF
Research Article Oncology

Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis

  • Text
  • PDF
Abstract

The histone demethylase PHF8 has been implicated in multiple pathological disorders, including X-linked mental retardation and tumorigenesis. However, it is not clear how the abundance and function of PHF8 are regulated. Here, we report that PHF8 physically associates with the deubiquitinase USP7. Specifically, we demonstrated that USP7 promotes deubiquitination and stabilization of PHF8, leading to the upregulation of a group of genes, including cyclin A2, that are critical for cell growth and proliferation. The USP7-encoding gene was also transcriptionally regulated by PHF8, via positive feedback. USP7 was overexpressed in breast carcinomas, and the level of expression positively correlated with expression of PHF8 and cyclin A2 and with the histological grade of breast cancer. We showed that USP7 promotes breast carcinogenesis by stabilizing PHF8 and upregulating cyclin A2 and that the interaction between USP7 and PHF8 is augmented during DNA damage. Moreover, USP7-promoted PHF8 stabilization conferred cellular resistance to genotoxic insults and was required for the recruitment of BLM and KU70, which are both essential for DNA double-strand break repair. Our study mechanistically links USP7 to epigenetic regulation and DNA repair. Moreover, these data support the pursuit of USP7 and PHF8 as potential targets for breast cancer intervention, especially in combination with chemo- or radiotherapies.

Authors

Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi

×

Figure 4

USP7 and PHF8 coregulate the expression of cyclin A2.

Options: View larger image (or click on image) Download as PowerPoint
USP7 and PHF8 coregulate the expression of cyclin A2.
(A) MCF-7 cells we...
(A) MCF-7 cells were transfected with control siRNA, PHF8 siRNA, or USP7 siRNA followed by RNA extraction and deep sequencing. Coregulated genes were clustered as indicated, and color key and histogram indicating the upregulation (red) or downregulation (green) of the targeted genes are shown (left panel). Coregulated genes were grouped and statistically analyzed according to KEGG pathways (right panel). (B) MCF-7 cells were transfected with the indicated siRNAs, followed by RNA extraction and qRT-PCR analysis of the expression of the indicated genes. (C) Soluble chromatin was immunoprecipitated from FLAG-PHF8–expressing MCF-7 cells with control IgG or antibodies against FLAG, H3K4me3, or PHF8, followed by qPCR analysis with primers for promoters of the indicated genes. (D) qChIP experiments analogous to C were performed with soluble chromatins from native MCF-7 cells (left panel) and USP7-depleted MCF-7 cells (right panel). GAPDH was used as a negative control. (E) Soluble chromatin from MCF-7 cells transfected with control siRNA or PHF8 siRNA was prepared for qChIP analysis using antibodies against the indicated histone modifications. (F) Soluble chromatin from MCF-7 cells was prepared for qChIP analysis with control IgG or anti-USP7. (G) MCF-7 cells with Dox-inducible expression of stably integrated USP7/WT (left panel) or USP7/C223S (right panel) were cultured in the absence or presence of increasing amounts of Dox. Cellular extracts were collected for Western blotting analysis. (H) MCF-7 cells with Dox-inducible expression of stably integrated FLAG-USP7 (left panel) or FLAG-PHF8 (right panel) were transfected with the indicated siRNAs and cultured in the absence or presence of Dox. Cellular extracts were prepared for Western blotting analysis. In B–F, each bar represents the mean ± SD for biological triplicate experiments. *P < 0.05 and **P < 0.01, 1-way ANOVA.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts